mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with 3-hydroxyflavone in 1 studies
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (3-hydroxyflavone) | Trials (3-hydroxyflavone) | Recent Studies (post-2010) (3-hydroxyflavone) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 3,657 | 84 | 2,242 |
| Protein | Taxonomy | mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin (IC50) | 3-hydroxyflavone (IC50) |
|---|---|---|---|
| Pyruvate kinase PKM | Homo sapiens (human) | 1.75 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.09 | |
| Aurora kinase B | Homo sapiens (human) | 4.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, JL; Leo, CH; Woodman, OL | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and 3-hydroxyflavone
| Article | Year |
|---|---|
3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes.
Topics: Animals; Antioxidants; Biomimetic Materials; Blood Glucose; Body Weight; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endothelium, Vascular; Flavonols; Mesenteric Arteries; Metalloporphyrins; Microvessels; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides; Vasodilation | 2011 |